You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oral AZA

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

Colorectal Cancer Trial in Baltimore (Oral CC-486, Romidepsin, MK-3475)

Completed
  • Colorectal Cancer
  • Oral CC-486
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 21, 2022

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 31, 2022

Lymphoma, T-Cell Trial in Charlottesville (Durvalumab, Pralatrexate, Romidepsin)

Recruiting
  • Lymphoma, T-Cell
  • Charlottesville, Virginia
    University of Virginia
Mar 16, 2022

MDS, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Australia (Azacitidine, CC-486)

Active, not recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Newcastle, New South Wales, Australia
  • +10 more
Mar 29, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (Milademetan, AZA)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Duarte, California
  • +4 more
Sep 14, 2021

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 18, 2022

Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)

Recruiting
  • Neoplasms
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

Not yet recruiting
  • AML, Adult
  • +4 more
  • Amiens, France
  • +19 more
Sep 1, 2023

Myelodysplastic Syndrome (MDS) Trial in Yamagata (ASTX030)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • Yamagata, Japan
    Yamagata University Hospital
Jun 20, 2022

NSCLC Trial in Worldwide (nab-paclitaxel IV, CC-486, Duravalumab)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • nab-paclitaxel IV
  • +2 more
  • San Francisco, California
  • +33 more
Jan 24, 2022

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

MDS Trial in Worldwide (Oral Azacitidine, Durvalumab)

Active, not recruiting
Has Results
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +65 more
Aug 19, 2022

Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (satralizumab, azathioprine (AZA), mycophenolate mofetil (MMF))

Active, not recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • Birmingham, Alabama
  • +52 more
Mar 16, 2022

Crohn's Disease Trial in Belgium, Finland, Netherlands (Infliximab, Prednisolone, Exclusive enteral nutrition)

Active, not recruiting
  • Crohn's Disease
  • Brussels, Belgium
  • +12 more
Aug 18, 2021

Crohn Disease, Azathioprine, Methotrexate Trial in Amiens (AZA capsules, MTX, blood sample)

Recruiting
  • Crohn Disease
  • +2 more
  • AZA capsules
  • +2 more
  • Amiens, France
    CHU Amiens
Sep 7, 2021

Myelodysplastic Syndrome (MDS) Trial in Worldwide (Venetoclax, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Fullerton, California
  • +219 more
Aug 24, 2022

Leukemia, Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia Trial in Tianjin (MAX-40279-01)

Recruiting
  • Leukemia
  • +3 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 29, 2021

Acute Myeloid Leukemia Trial in Worldwide (Pracinostat, Placebos, Azacitidine)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Phoenix, Arizona
  • +137 more
Mar 9, 2022

Methotrexate and Azathioprine as Background Treatment for

Not yet recruiting
  • Uveitis
    • Brest, France
      CHU de Brest
    May 10, 2022

    Thrombocytopenia, Isolated, Stem Cell Transplant Complications Trial in Suzhou (Azacitidine, N Acetyl L Cysteine)

    Not yet recruiting
    • Thrombocytopenia, Isolated
    • Stem Cell Transplant Complications
    • Suzhou, Jiangsu, China
      The first affiliated hospital of Soochow University
    Nov 8, 2021

    GM2 Gangliosidosis, Niemann-Pick Disease, Type C Trial in Curitiba, Porto Alegre, Rio De Janeiro (AZ-3102 (Dose 1), Placebo,

    Not yet recruiting
    • GM2 Gangliosidosis
    • Niemann-Pick Disease, Type C
    • AZ-3102 (Dose 1)
    • +2 more
    • Curitiba, Brazil
    • +2 more
    Feb 24, 2023

    PTCL Trial in Long Beach, New Haven, Charlottesville (Azacytidine, Romidepsin, Belinostat)

    Recruiting
    • PTCL
    • Long Beach, California
    • +2 more
    Mar 1, 2022

    MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +3 more
    • Subcutaneous azacitidine
    • Oral decitabine/cedazuridine
    • Newcastle, New South Wales, Australia
      Calvary Mater Newcastle
    May 29, 2023